SCNH 2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells *

The gut hormone apelin is a major therapeutic focus for several diseases involving inflammation and aberrant cell growth. We investigated whether apelin-36 contained alternative bioactive peptides associated with normal physiology or disease. Amino acid sequence analysis of apelin-36 identified an amidation motif consistent with the formation of a secondary bioactive peptide (SCNH2). SCNH2 is proven to be mitogenic and chemotactic in normal/malignant cells and augments angiogenesis via a PTX-resistant/CTX-sensitive G protein-coupled receptor (GPCR). Notably, SCNH2 is substantially more potent and sensitive than apelin-13 and vascular endothelial growth factor-A. Endogenous SCNH2 is highly expressed in human tumors and placenta and in mouse embryonic tissues. Our findings demonstrate that SCNH2 is a new apelinergic member with critical pluripotent roles in angiogenesis related diseases and embryogenesis via a non-APJ GPCR.

[1]  Y. Okamoto,et al.  The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy , 2012, Oncogene.

[2]  S. Kim,et al.  Hypoxia-induced up-regulation of apelin is associated with a poor prognosis in oral squamous cell carcinoma patients. , 2012, Oral oncology.

[3]  M. Plaisier.  Decidualisation and angiogenesis. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[4]  K. Naruse,et al.  Secretion of cytokines by villous cytotrophoblast and extravillous trophoblast in the first trimester of human pregnancy. , 2010, Journal of reproductive immunology.

[5]  J. Tímár,et al.  Apelin Expression in Human Non-small Cell Lung Cancer: Role in Angiogenesis and Prognosis , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  A. Leite-Moreira,et al.  The apelinergic system: a promising therapeutic target , 2010, Expert opinion on therapeutic targets.

[7]  H. Volkoff,et al.  Apelin in goldfish (Carassius auratus): Cloning, distribution and role in appetite regulation , 2009, Peptides.

[8]  M. Eyries,et al.  Hypoxia-Induced Apelin Expression Regulates Endothelial Cell Proliferation and Regenerative Angiogenesis , 2008, Circulation research.

[9]  G. Greeley,et al.  A possible role for hypoxia-induced apelin expression in enteric cell proliferation. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[10]  S. Davidson,et al.  Apelin exhibits cardioprotection against ischaemia reperfusion injury , 2007 .

[11]  S. Tang,et al.  Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways , 2007, Peptides.

[12]  D. Sarkar,et al.  Role of Protein Kinase C-Ras-MAPK p44/42 in Ethanol and Transforming Growth Factor-β3-Induced Basic Fibroblast Growth Factor Release from Folliculostellate Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.

[13]  A. Ebert,et al.  Role of human cripto-1 in tumor angiogenesis. , 2005, Journal of the National Cancer Institute.

[14]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[15]  G. Greeley,et al.  Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. , 2004, Endocrinology.

[16]  Nozomi Fukai,et al.  Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells , 2003, Regulatory Peptides.

[17]  H. Lahlou,et al.  Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. , 2002, Biochemical and biophysical research communications.

[18]  E. Shakhnovich,et al.  Understanding hierarchical protein evolution from first principles. , 2001, Journal of molecular biology.

[19]  S. Hinuma,et al.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. , 1998, Biochemical and biophysical research communications.

[20]  K. Kangawa,et al.  The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. , 1998, Biochemical and biophysical research communications.

[21]  J. Pintar,et al.  Embryonic and uterine expression patterns of peptidylglycine alpha-amidating monooxygenase transcripts suggest a widespread role for amidated peptides in development. , 1997, Developmental biology.

[22]  I. Reid,et al.  Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. , 1997, The American journal of physiology.

[23]  P. Casey,et al.  Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. , 1997, The Biochemical journal.

[24]  R. Raffa,et al.  An examination of the relationship between mu-opioid antinociceptive efficacy and G-protein coupling using pertussis and cholera toxins. , 1997, Life sciences.

[25]  J. Siegfried,et al.  Expression of adrenomedullin in normal human lung and in pulmonary tumors. , 1995, Endocrinology.

[26]  Y. Hirata,et al.  Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. , 1994, Endocrinology.

[27]  C. Cordon-Cardo,et al.  Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. , 1993, Journal of the National Cancer Institute.

[28]  F. Cuttitta.  Peptide amidation: Signature of bioactivity , 1993, The Anatomical record.

[29]  J. Siegfried,et al.  A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  V. Mutt,et al.  Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides , 1980, Nature.

[31]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[32]  P. Zorzi,et al.  The aortic ring model of angiogenesis. , 2008, Methods in enzymology.

[33]  A. Zijlstra,et al.  Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells. , 2006, Blood.

[34]  L. Montuenga,et al.  Expression of Adrenomedullin and Its Receptor during Embryogenesis Suggests Autocrine or Paracrine Modes of Action. , 1997, Endocrinology.

[35]  A. Gilman,et al.  G proteins: transducers of receptor-generated signals. , 1987, Annual review of biochemistry.

[36]  A. Fukamizu,et al.  Identification and functional analysis of endothelial tip cell–enriched genes , 2022 .